Drs Camidge and Zirkelbach discuss Zirkelbach's first pharmacokinetics forays and her involvement with reforming dose optimization in drug development.
Jeanne Fourie Zirkelbach, PhD
Advertisement
Articles by Jeanne Fourie Zirkelbach, PhD
Advertisement
Advertisement
Advertisement
Trending on OncLive
1
Targeted Therapies, ADCs, and Oral SERD Combos Expand Treatment Possibilities Across Breast Cancer Settings
2
Head and Neck Oncologists Highlight Practice-Informing Research From ASCO 2026
3
In Vivo CAR T-Cell Therapy Drives Responses and MRD Negativity in R/R Myeloma
4
Dr Galsky on the Current Roles of Biomarkers in Bladder Cancer
5